Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Internal Dialogue as a Mediator of the Relationship Between Prayer and Well-Being.

Puchalska-Wasyl MM, Zarzycka B.

J Relig Health. 2019 Nov 9. doi: 10.1007/s10943-019-00943-2. [Epub ahead of print]

PMID:
31707518
2.

Harnessing Ion-Binding Sites for GPCR Pharmacology.

Zarzycka B, Zaidi SA, Roth BL, Katritch V.

Pharmacol Rev. 2019 Oct;71(4):571-595. doi: 10.1124/pr.119.017863. Review.

PMID:
31551350
3.

O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo Activity.

Levine PM, Balana AT, Sturchler E, Koole C, Noda H, Zarzycka B, Daley EJ, Truong TT, Katritch V, Gardella TJ, Wootten D, Sexton PM, McDonald P, Pratt MR.

J Am Chem Soc. 2019 Sep 11;141(36):14210-14219. doi: 10.1021/jacs.9b05365. Epub 2019 Aug 28.

PMID:
31418572
4.

Illness perception and affective symptoms in gastrointestinal cancer patients: A moderated mediation analysis of meaning in life and coping.

Krok D, Telka E, Zarzycka B.

Psychooncology. 2019 Aug;28(8):1728-1734. doi: 10.1002/pon.5157. Epub 2019 Jul 2.

PMID:
31219217
5.

Religious comfort and anxiety in women with cancer: The mediating role of hope and moderating role of religious struggle.

Zarzycka B, Śliwak J, Krok D, Ciszek P.

Psychooncology. 2019 Sep;28(9):1829-1835. doi: 10.1002/pon.5155. Epub 2019 Jul 10.

PMID:
31218773
6.
7.

Flow Cytometry Analysis of Antibacterial Effects of Universal Dentin Bonding Agents on Streptococcus mutans.

Lapinska B, Konieczka M, Zarzycka B, Sokolowski K, Grzegorczyk J, Lukomska-Szymanska M.

Molecules. 2019 Feb 1;24(3). pii: E532. doi: 10.3390/molecules24030532.

8.

Can Religious and Spiritual Struggle Enhance Well-Being? Exploring the Mediating Effects of Internal Dialogues.

Zarzycka B, Puchalska-Wasyl MM.

J Relig Health. 2019 Jan 2. doi: 10.1007/s10943-018-00755-w. [Epub ahead of print]

PMID:
30604328
9.

Publisher Correction: Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor.

Audet M, White KL, Breton B, Zarzycka B, Han GW, Lu Y, Gati C, Batyuk A, Popov P, Velasquez J, Manahan D, Hu H, Weierstall U, Liu W, Shui W, Katritch V, Cherezov V, Hanson MA, Stevens RC.

Nat Chem Biol. 2019 Feb;15(2):206. doi: 10.1038/s41589-018-0214-1.

PMID:
30573766
10.

Exploring Pairwise Chemical Crosslinking To Study Peptide-Receptor Interactions.

Seidel L, Zarzycka B, Katritch V, Coin I.

Chembiochem. 2019 Mar 1;20(5):683-692. doi: 10.1002/cbic.201800582. Epub 2019 Jan 25.

PMID:
30565820
11.

Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor.

Audet M, White KL, Breton B, Zarzycka B, Han GW, Lu Y, Gati C, Batyuk A, Popov P, Velasquez J, Manahan D, Hu H, Weierstall U, Liu W, Shui W, Katritch V, Cherezov V, Hanson MA, Stevens RC.

Nat Chem Biol. 2019 Jan;15(1):11-17. doi: 10.1038/s41589-018-0160-y. Epub 2018 Dec 3. Erratum in: Nat Chem Biol. 2019 Feb;15(2):206.

12.

A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 Receptor.

Fyfe TJ, Zarzycka B, Lim HD, Kellam B, Mistry SN, Katrich V, Scammells PJ, Lane JR, Capuano B.

J Med Chem. 2019 Jan 10;62(1):174-206. doi: 10.1021/acs.jmedchem.7b01565. Epub 2018 May 15.

PMID:
29683325
13.

Spiritual Growth or Decline and Meaning-Making as Mediators of Anxiety and Satisfaction with Life During Religious Struggle.

Zarzycka B, Zietek P.

J Relig Health. 2019 Aug;58(4):1072-1086. doi: 10.1007/s10943-018-0598-y.

14.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

15.

The Impact of Caregivers' Anxiety on Patients' Anxiety before Fast-Track Knee Arthroplasty.

Zietek P, Zarzycka B, Zietek J, Stepien-Slodkowska M, Sienko-Awierianow E, Kotrych D, Dobiecki K.

Acta Chir Orthop Traumatol Cech. 2017;84(4):292-298.

PMID:
28933332
16.

Antibacterial Activity of Commercial Dentine Bonding Systems against E. faecalis-Flow Cytometry Study.

Lukomska-Szymanska M, Konieczka M, Zarzycka B, Lapinska B, Grzegorczyk J, Sokolowski J.

Materials (Basel). 2017 Apr 29;10(5). pii: E481. doi: 10.3390/ma10050481.

17.

Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.

Seidel L, Zarzycka B, Zaidi SA, Katritch V, Coin I.

Elife. 2017 Aug 3;6. pii: e27711. doi: 10.7554/eLife.27711.

18.

Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.

Aarts SABM, Seijkens TTP, Kusters PJH, van der Pol SMA, Zarzycka B, Heijnen PDAM, Beckers L, den Toom M, Gijbels MJJ, Boon L, Weber C, de Vries HE, Nicolaes GAF, Dijkstra CD, Kooij G, Lutgens E.

J Neuroinflammation. 2017 May 12;14(1):105. doi: 10.1186/s12974-017-0875-9.

19.
20.

Antibacterial Properties of Calcium Fluoride-Based Composite Materials: In Vitro Study.

Łukomska-Szymańska M, Zarzycka B, Grzegorczyk J, Sokołowski K, Półtorak K, Sokołowski J, Łapińska B.

Biomed Res Int. 2016;2016:1048320. doi: 10.1155/2016/1048320. Epub 2016 Dec 8.

21.

Stabilization of protein-protein interaction complexes through small molecules.

Zarzycka B, Kuenemann MA, Miteva MA, Nicolaes GAF, Vriend G, Sperandio O.

Drug Discov Today. 2016 Jan;21(1):48-57. doi: 10.1016/j.drudis.2015.09.011. Epub 2015 Oct 3. Review.

PMID:
26434617
22.

iPPI-DB: an online database of modulators of protein-protein interactions.

Labbé CM, Kuenemann MA, Zarzycka B, Vriend G, Nicolaes GA, Lagorce D, Miteva MA, Villoutreix BO, Sperandio O.

Nucleic Acids Res. 2016 Jan 4;44(D1):D542-7. doi: 10.1093/nar/gkv982. Epub 2015 Oct 1.

23.

Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.

Zarzycka B, Nicolaes GA, Lutgens E.

Expert Rev Clin Pharmacol. 2015 May;8(3):297-313. doi: 10.1586/17512433.2015.1025052. Epub 2015 Apr 4. Review.

PMID:
25843158
24.

Discovery of small molecule CD40-TRAF6 inhibitors.

Zarzycka B, Seijkens T, Nabuurs SB, Ritschel T, Grommes J, Soehnlein O, Schrijver R, van Tiel CM, Hackeng TM, Weber C, Giehler F, Kieser A, Lutgens E, Vriend G, Nicolaes GA.

J Chem Inf Model. 2015 Feb 23;55(2):294-307. doi: 10.1021/ci500631e. Epub 2015 Jan 27.

PMID:
25622654
25.

Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice.

van den Berg SM, Seijkens TT, Kusters PJ, Zarzycka B, Beckers L, den Toom M, Gijbels MJ, Chatzigeorgiou A, Weber C, de Winther MP, Chavakis T, Nicolaes GA, Lutgens E.

Int J Obes (Lond). 2015 May;39(5):782-90. doi: 10.1038/ijo.2014.198. Epub 2014 Nov 13.

PMID:
25394307
26.

Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance.

Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S, van den Berg S, Soehnlein O, Winkels H, Beckers L, Lievens D, Driessen A, Kusters P, Biessen E, Garcia-Martin R, Klotzsche-von Ameln A, Gijbels M, Noelle R, Boon L, Hackeng T, Schulte KM, Xu A, Vriend G, Nabuurs S, Chung KJ, Willems van Dijk K, Rensen PC, Gerdes N, de Winther M, Block NL, Schally AV, Weber C, Bornstein SR, Nicolaes G, Chavakis T, Lutgens E.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2686-91. doi: 10.1073/pnas.1400419111. Epub 2014 Feb 3. Erratum in: Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4644. Schulte, Klaus [corrected to Schulte, Klaus-Martin].

27.

[The effects of topical fluoridation of enamel on the growth of cariogenic bacteria contained in the dental plaque].

Płuciennik-Stronias M, Zarzycka B, Bołtacz-Rzepkowska E.

Med Dosw Mikrobiol. 2013;65(2):129-32. Polish.

PMID:
24187711
28.

[The effects of topical fluoridation of Ketac Molar Aplicap glass-ionomer material on the growth of cariogenic bacteria contained in the dental plaque].

Płuciennik-Stronias M, Zarzycka B, Bołtacz-Rzepkowska E.

Med Dosw Mikrobiol. 2013;65(1):65-70. Polish.

PMID:
24180133
29.

Explaining the relationship between post-critical beliefs and sense of coherence in Polish young, middle, and late adults.

Zarzycka B, Rydz E.

J Relig Health. 2014 Jun;53(3):834-48. doi: 10.1007/s10943-013-9680-7.

30.

Enzyme-specific activation versus leaving group ability.

de Beer RJ, Bögels B, Schaftenaar G, Zarzycka B, Quaedflieg PJ, van Delft FL, Nabuurs SB, Rutjes FP.

Chembiochem. 2012 Aug 13;13(12):1785-90. doi: 10.1002/cbic.201200227. Epub 2012 Jul 23.

31.

Comparative analysis of pharmacophore screening tools.

Sanders MP, Barbosa AJ, Zarzycka B, Nicolaes GA, Klomp JP, de Vlieg J, Del Rio A.

J Chem Inf Model. 2012 Jun 25;52(6):1607-20. doi: 10.1021/ci2005274. Epub 2012 Jun 13.

PMID:
22646988
32.

In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.

Greupink R, Nabuurs SB, Zarzycka B, Verweij V, Monshouwer M, Huisman MT, Russel FG.

Toxicol Sci. 2012 Sep;129(1):35-48. doi: 10.1093/toxsci/kfs188. Epub 2012 May 28.

PMID:
22641618
33.

Papain-specific activating esters in aqueous dipeptide synthesis.

de Beer RJ, Zarzycka B, Mariman M, Amatdjais-Groenen HI, Mulders MJ, Quaedflieg PJ, van Delft FL, Nabuurs SB, Rutjes FP.

Chembiochem. 2012 Jun 18;13(9):1319-26. doi: 10.1002/cbic.201200017. Epub 2012 May 21.

PMID:
22615272
34.

Papain-catalyzed peptide bond formation: enzyme-specific activation with guanidinophenyl esters.

de Beer RJ, Zarzycka B, Amatdjais-Groenen HI, Jans SC, Nuijens T, Quaedflieg PJ, van Delft FL, Nabuurs SB, Rutjes FP.

Chembiochem. 2011 Sep 19;12(14):2201-7. doi: 10.1002/cbic.201100267. Epub 2011 Aug 8.

PMID:
21826775
35.

The interplay between post-critical beliefs and anxiety: an exploratory study in a Polish sample.

Śliwak J, Zarzycka B.

J Relig Health. 2012 Jun;51(2):419-30. doi: 10.1007/s10943-010-9367-2.

36.

[Prevalence IgG antibodies against Bartonella henselae in children with lymphadenopathy].

Zarzycka B, Pieczara A, Skowron-Kobos J, Krzemiński Z.

Przegl Epidemiol. 2008;62(4):759-65. Polish.

PMID:
19209738
37.

[The influence of pregnancy on progression of diabetic retinopathy].

Proniewska-Skretek E, Zalewska R, Kraśnicki P, Zarzycka B, Zarzycki W, Mariak Z, Górska M.

Klin Oczna. 2007;109(7-9):308-11. Polish.

PMID:
18260286
38.

[The correlation between the number of polymorphonuclear leukocytes in human oral cavity and the counts of some bacteria].

Zarzycka B, Płuciennik M, Krzemiński Z.

Med Dosw Mikrobiol. 2005;57(2):225-9. Polish.

PMID:
16134395
39.

[Pregnancy complicated by type I, type II and gestational diabetes: experiences from the diabetic-obstetric center of Białystock].

Kinalska I, Kinalski M, Telejko B, Topolska J, Zarzycka B.

Pol Arch Med Wewn. 1999 Dec;102(6):1039-45. Polish.

PMID:
11072539
40.

[Peptide C and insulin after delivery in women with gestational diabetes].

Kinalski M, Zarzycki W, Zarzycka B, Kinalska I.

Pol Arch Med Wewn. 1997 May;97(5):411-7. Polish.

PMID:
9411418
41.

[Acceptance and subjective evaluation of intensive insulin therapy and an educational program by pregnant women with insulin dependent diabetes].

Zarzycki W, Chałupczak R, Zarzycka B, Jakubczyk D, Kinalska I.

Przegl Lek. 1994;51(8):339-42. Polish.

PMID:
7871211
42.

[Activity of factor XIII and various lipid components of blood serum in patients with diabetes mellitus].

Zarzycka B, Pietruska Z, Kinalska I.

Pol Arch Med Wewn. 1987 Mar;77(3):94-100. Polish. No abstract available.

PMID:
3275395
43.

[Malignant neoplasm of the pituitary gland as a cause of the amenorrhea-galactorrhea syndrome].

Zarzycki W, Zabłocki M, Zarzycka B.

Wiad Lek. 1987 Feb 1;40(3):205-7. Polish. No abstract available.

PMID:
3617741
44.

[Fibrinopeptide A in patients with diabetes mellitus complicated by angiopathy].

Kłoczko J, Wojtukiewicz M, Bielawiec M, Borowska M, Zarzycka B, Kinalska I.

Pol Tyg Lek. 1986 Nov 24;41(47):1483-5. Polish. No abstract available.

PMID:
3562335
45.

Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.

Kłoczko J, Wojtukiewicz M, Bielawiec M, Zarzycka B, Kinalska I.

Acta Haematol. 1986;76(2-3):81-5.

PMID:
2433883
46.

[Case of Reye's syndrome in an adult].

Zarzycki W, Zarzycka B.

Wiad Lek. 1983 Jun 1;36(11):935-8. Polish. No abstract available.

PMID:
6624105
47.

[Desmofibrinogenic activity of factor XIII and thiol group levels of the plasma of patients with rheumatoid arthritis treated with levamisole].

Zarzycka B, Pietruska Z, Górska M.

Pol Tyg Lek. 1983 Feb 14;38(7):209-12. Polish. No abstract available.

PMID:
6866835

Supplemental Content

Loading ...
Support Center